Citation Impact
Citing Papers
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge
2009
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Rodent-borne diseases and their risks for public health
2009 Standout
Hantaviruses: Immunology, Treatment, and Prevention
2004
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model
2017
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
2018
Cathepsin L and Cathepsin B Mediate Reovirus Disassembly in Murine Fibroblast Cells
2002
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Intracellular Protein Delivery and Gene Transfection by Electroporation Using a Microneedle Electrode Array
2012
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Hantavirus pulmonary syndrome
2011
Efficient bunyavirus rescue from cloned cDNA
2004
A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies
2005
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Vaccines: Correlates of Vaccine‐Induced Immunity
2008
Duration of antiviral immunity after smallpox vaccination
2003 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Hantavirus Pulmonary Syndrome: The New American Hemorrhagic Fever
2002
COVID-19: A promising cure for the global panic
2020 Standout
Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus
2010
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
2021
DNA vaccines: ready for prime time?
2008
Antibodies against viruses: passive and active immunization
2008
Oncolytic viruses: a new class of immunotherapy drugs
2015
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine
2010
SARS vaccines: where are we?
2009
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Uncovering the mysteries of hantavirus infections
2013
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
2011 StandoutNature
Microneedles with Intrinsic Immunoadjuvant Properties: Microfabrication, Protein Stability, and Modulated Release
2010
Intracellular antibody‐mediated immunity and the role of TRIM21
2011
An electrically active microneedle array for electroporation
2009
Transdermal drug delivery
2008 Standout
Microneedle-Based Vaccines
2009
Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread
2017 StandoutNobel
Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
2008
Control of Stem Cell Fate by Physical Interactions with the Extracellular Matrix
2009 Standout
Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin
2005
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Selective CD4+ T Cell Help for Antibody Responses to a Large Viral Pathogen: Deterministic Linkage of Specificities
2008
SARS-CoV-2 variants, spike mutations and immune escape
2021 Standout
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
2003
Micro-scale devices for transdermal drug delivery
2008
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
Microneedles for drug and vaccine delivery
2012 Standout
Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment
2009
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Electroporation-enhanced delivery of nucleic acid vaccines
2014
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
Leukocyte-Derived IFN-α/β and Epithelial IFN-λ Constitute a Compartmentalized Mucosal Defense System that Restricts Enteric Virus Infections
2015
Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice
2010
Microneedles for transdermal drug delivery: a minireview
2007
Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation
2010
Use of Conventional or Replicating Nucleic Acid-Based Vaccines and Recombinant Semliki Forest Virus-Derived Particles for the Induction of Immune Responses Against Hepatitis C Virus Core and E2 Antigens
2000
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
2020
Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice
2010
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Animal cell invasion by a large nonenveloped virus: reovirus delivers the goods
2003
Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~!
2010
A high-capacity, hybrid electro-microneedle for in-situ cutaneous gene transfer
2011
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance
2014
DNA Vaccines: Recent Developments and Future Possibilities
2006
Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion
2015
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection
2002 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Molecular Biology of Rift Valley Fever Virus
2010
Intracellular antibody receptor TRIM21 prevents fatal viral infection
2013
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
2017
Elevated Generation of Reactive Oxygen/Nitrogen Species in Hantavirus Cardiopulmonary Syndrome
2002
Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5
2009
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Diversity in the Acute CD8 T Cell Response to Vaccinia Virus in Humans
2005
Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement
2008
Dissociation between Epitope Hierarchy and Immunoprevalence in CD8 Responses to Vaccinia Virus Western Reserve
2008
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection
2015
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Enhanced Immunogenicity to Mycobacterium tuberculosis by Vaccination with an Alphavirus Plasmid Replicon Expressing Antigen 85A
2002
Kinetics of Immune Responses in Deer Mice Experimentally Infected with Sin Nombre Virus
2012
RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila
2010 StandoutNobel
Emerging and re-emerging infectious diseases
2002
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
2013 StandoutNobel
Uncovering the Interplay Between CD8, CD4 and Antibody Responses to Complex Pathogens
2010
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles
2002
Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
2013
Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions
2002
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus
2013
The mechanochemical basis of cell and tissue regulation.
2004
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
2006 StandoutNobel
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Influences of Glycosylation on Antigenicity, Immunogenicity, and Protective Efficacy of Ebola Virus GP DNA Vaccines
2006
Transmission Study of Andes Hantavirus Infection in Wild Sigmodontine Rodents
2004
Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array
2008
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Kunjin Virus Replicon Vaccine Vectors Induce Protective CD8+T-Cell Immunity
2002
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization
2009
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination
2008
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses
2007
C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1
2012 StandoutNobel
Pathogenic Hantaviruses Direct the Adherence of Quiescent Platelets to Infected Endothelial Cells
2010
The gene gun: current applications in cutaneous gene therapy
2000
Works of Jay W. Hooper being referenced
Cross-Protection Conferred by Filovirus Virus-Like Particles Containing Trimeric Hybrid Glycoprotein
2014
Smallpox DNA Vaccine Protects Nonhuman Primates against Lethal Monkeypox
2004
Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus
2005
A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
2014
Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge
2006
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
2020
DNA Vaccination with Hantavirus M Segment Elicits Neutralizing Antibodies and Protects against Seoul Virus Infection
1999
Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein
2007
Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies
2011
Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus
2005
Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates
2003
Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine
2008
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation
2014
The Syrian hamster model of hantavirus pulmonary syndrome
2012
DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)
2012
Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates
2005
Comparison of the Protective Efficacy of Naked DNA, DNA-based Sindbis Replicon, and Packaged Sindbis Replicon Vectors Expressing Hantavirus Structural Genes in Hamsters
1999
Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges
2015
Treatment of hantavirus pulmonary syndrome
2007
Rescue of hantaan virus minigenomes
2003
Vaccines Against Hantaviruses
2001
A Lethal Disease Model for Hantavirus Pulmonary Syndrome
2001
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome
2012
DNA Vaccination with Vaccinia Virus L1R and A33R Genes Protects Mice against a Lethal Poxvirus Challenge
2000
The M2 Gene Segment Is Involved in the Capacity of Reovirus Type 3 Abney to Induce the Oily Fur Syndrome in Neonatal Mice, a S1 Gene Segment-Associated Phenotype
2002
Study of Andes virus entry and neutralization using a pseudovirion system
2009
DNA vaccines for HFRS: Laboratory and clinical studies
2013
DNA vaccine–derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome
2014
T Cells Are Not Required for Pathogenesis in the Syrian Hamster Model of Hantavirus Pulmonary Syndrome
2011
Monoclonal antibodies to reovirus sigma 1 and mu 1 proteins inhibit chromium release from mouse L cells
1996
Reovirus M2 gene is associated with chromium release from mouse L cells
1993
Immune Serum Produced by DNA Vaccination Protects Hamsters against Lethal Respiratory Challenge with Andes Virus
2007
Human T-Cell Responses to Vaccinia Virus Envelope Proteins
2006
Temporal Analysis of Andes Virus and Sin Nombre Virus Infections of Syrian Hamsters
2007
Ribavirin Protects Syrian Hamsters against Lethal Hantavirus Pulmonary Syndrome — After Intranasal Exposure to Andes Virus
2013
DNA Vaccination with the Hantaan Virus M Gene Protects Hamsters against Three of Four HFRS Hantaviruses and Elicits a High-Titer Neutralizing Antibody Response in Rhesus Monkeys
2001
Role of the mu 1 protein in reovirus stability and capacity to cause chromium release from host cells
1996
Active and Passive Vaccination against Hantavirus Pulmonary Syndrome with Andes Virus M Genome Segment-Based DNA Vaccine
2003